Cleared Traditional

K945535 - GLENROE ORTHO-SIL

K945535 is an FDA 510(k) clearance for GLENROE ORTHO-SIL, manufactured by Glenroe Technologies. The device is a Class 1 Dental device with product code EGD cleared through the Traditional 510(k) pathway after a 74-day FDA review.

K945535 · Glenroe Technologies · Dental device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jan 1995
Decision
74d
Days
Class 1
Risk

K945535 is an FDA 510(k) clearance for the GLENROE ORTHO-SIL. Classified as Wax, Dental, Intraoral (product code EGD), Class I - General Controls.

Submitted by Glenroe Technologies (Bradenton, US). The FDA issued a Cleared decision on January 27, 1995 after a review of 74 days - a notably fast clearance cycle.

This device falls under the Dental FDA review panel, regulated under 21 CFR 872.6890 - the FDA dental device regulatory framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Glenroe Technologies devices

FDA 510(k) Submission Details - K945535

510(k) Number K945535 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 14, 1994
Decision Date January 27, 1995
Days to Decision 74 days
Submission Type Traditional
Review Panel Dental (DE)
Summary Statement
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
53d faster than avg
Panel avg: 127d · This submission: 74d
Pathway characteristics
Predicate-based equivalence.

EGD Device Classification - Class 1, General Controls

Product Code EGD Wax, Dental, Intraoral
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 872.6890
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.